First-Line Options for Type 2 Diabetes

This month's TRC Hot Topic on-demand webinar features an expert panel discussion and clinical guidance on First-Line Options for Type 2 Diabetes. Listen as Steven E. Nissen, MD, MACC, Chief Academic Officer, Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, Professor of Medicine, Cleveland Clinic Lerner School of Medicine at Case Western Reserve University, Cleveland, OH, and other panelists discuss and answer common clinical questions, including:

What are the benefits of metformin, GLP-1 agonists, and SGLT2 inhibitors for type 2 diabetes?
What are downsides of metformin, GLP-1 agonists, and SGLT2 inhibitors?
Why are first-line options for type 2 diabetes shifting?
What are considerations for choosing a first-line med for type 2 diabetes?
Which is the best option for patients with CV disease, heart failure, or chronic kidney disease?

Don't miss this important on-demand webinar! Fill out the form to watch instantly.

View our website for a list of all our free on-demand webinars.

Hot Topic On-Demand Webinar Series

First-Line Options for Type 2 Diabetes

Don't miss this important on-demand webinar! Fill out the form to watch instantly.

Please register to instantly view the webinar:

About TRC Healthcare

TRC Healthcare provides unbiased education, training, and support to every healthcare professional to reduce knowledge gaps, encourage evidence-based practice, lower costs, and deliver better patient outcomes.